Literature DB >> 8083970

Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice.

T M Collins1, M R Quirk, M C Jordan.   

Abstract

Circulating leukocytes are important in dissemination of cytomegalovirus (CMV) infection in humans. In the mouse model of murine CMV infection (MCMV), it has been shown that infection peaks on days 5 to 7 after experimental infection, when 0.01 to 0.1% of the circulating leukocytes contain viral DNA. In our laboratory, MCMV DNA was detected by in situ hybridization predominantly in the mononuclear cells on day 6 after acute infection. Infectious virus was recovered from day 6 mononuclear fractions in 16 of 16 mice compared with that from day 6 polymorphonuclear fractions in 4 of 16 mice. An eclipse phenomenon was noted in the blood leukocytes by quantitative blot hybridization: the amount of MCMV DNA present was small on day 2, diminished on days 3 and 4, and then increased markedly on days 5 and 6 in both the mononuclear and polymorphonuclear fractions immediately following viral augmentation in the liver and spleen. MCMV immediate-early and glycoprotein B (late) transcripts were present in pooled mononuclear fractions only on day 6 of acute infection but not in pooled polymorphonuclear fractions. Collectively, these data demonstrate that (i) circulating leukocytes, predominantly mononuclear, are involved in dissemination of MCMV; (ii) a primary viremia with dissemination of MCMV to reticuloendothelial organs (liver and spleen) occurs and is followed by viral amplification and a subsequent, more intense secondary viremia; and (iii) immediate-early viral mRNA and glycoprotein B mRNA transcripts are detectable only during peak infection on day 6 in mononuclear leukocytes but not in polymorphonuclear leukocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8083970      PMCID: PMC237051     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Human cytomegalovirus infection of the major leukocyte subpopulations and evidence for initial viral replication in polymorphonuclear leukocytes from viremic patients.

Authors:  G Gerna; D Zipeto; E Percivalle; M Parea; M G Revello; R Maccario; G Peri; G Milanesi
Journal:  J Infect Dis       Date:  1992-12       Impact factor: 5.226

2.  Cytomegaloviremia in children with acute lymphocytic leukemia.

Authors:  F Cox; W T Hughes
Journal:  J Pediatr       Date:  1975-08       Impact factor: 4.406

3.  Comparison of rates of virus isolation from leukocyte populations separated from blood by conventional and Ficoll-Paque/Macrodex methods.

Authors:  C L Howell; M J Miller; W J Martin
Journal:  J Clin Microbiol       Date:  1979-10       Impact factor: 5.948

4.  Immunosuppression reactivates and disseminates latent murine cytomegalovirus.

Authors:  M C Jordan; J D Shanley; J G Stevens
Journal:  J Gen Virol       Date:  1977-11       Impact factor: 3.891

5.  Characteristics of infection of B and T lymphocytes from mice after inoculation with cytomegalovirus.

Authors:  B C Wu; M Ho
Journal:  Infect Immun       Date:  1979-06       Impact factor: 3.441

6.  High levels of circulating cytomegalovirus DNA reflect visceral organ disease in viremic immunosuppressed patients other than marrow recipients.

Authors:  R L Saltzman; M R Quirk; M C Jordan
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

7.  Human cytomegalovirus (HCMV) late-mRNA detection in peripheral blood of AIDS patients: diagnostic value for HCMV disease compared with those of viral culture and HCMV DNA detection.

Authors:  J Gozlan; J M Salord; C Chouaïd; C Duvivier; O Picard; M C Meyohas; J C Petit
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

8.  Detection of latent cytomegalovirus DNA in diverse organs of mice.

Authors:  T Collins; C Pomeroy; M C Jordan
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

9.  Latent murine cytomegalovirus DNA in splenic stromal cells of mice.

Authors:  C Pomeroy; P J Hilleren; M C Jordan
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

10.  Identification of the murine cytomegalovirus glycoprotein B gene and its expression by recombinant vaccinia virus.

Authors:  M Rapp; M Messerle; B Bühler; M Tannheimer; G M Keil; U H Koszinowski
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more
  35 in total

1.  Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus.

Authors:  H Hengel; U Reusch; G Geginat; R Holtappels; T Ruppert; E Hellebrand; U H Koszinowski
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection In Vivo.

Authors:  Joseph Yunis; Helen E Farrell; Kimberley Bruce; Clara Lawler; Orry Wyer; Nicholas Davis-Poynter; Ilija Brizić; Stipan Jonjić; Barbara Adler; Philip G Stevenson
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

3.  Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination.

Authors:  Satoshi Noda; Shirley A Aguirre; Andrew Bitmansour; Janice M Brown; Timothy E Sparer; Jing Huang; Edward S Mocarski
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

4.  Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.

Authors:  V J Cavanaugh; R M Stenberg; T L Staley; H W Virgin; M R MacDonald; S Paetzold; H E Farrell; W D Rawlinson; A E Campbell
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

5.  Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection.

Authors:  N Saederup; S A Aguirre; T E Sparer; D M Bouley; E S Mocarski
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

6.  Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.

Authors:  Helen E Farrell; Nick Davis-Poynter; Kimberley Bruce; Clara Lawler; Lars Dolken; Michael Mach; Philip G Stevenson
Journal:  J Virol       Date:  2015-04-29       Impact factor: 5.103

7.  Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.

Authors:  Helen E Farrell; Clara Lawler; Martha T Oliveira; Nick Davis-Poynter; Philip G Stevenson
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

8.  Effective inhibition in animals of viral pathogenesis by a ribozyme derived from RNase P catalytic RNA.

Authors:  Yong Bai; Phong Trang; Hongjian Li; Kihoon Kim; Tianhong Zhou; Fenyong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-28       Impact factor: 11.205

9.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

10.  Amphipathic DNA polymers exhibit antiviral activity against systemic murine Cytomegalovirus infection.

Authors:  Rhonda D Cardin; Fernando J Bravo; Andrea P Sewell; James Cummins; Louis Flamand; Jean-Marc Juteau; David I Bernstein; Andrew Vaillant
Journal:  Virol J       Date:  2009-12-02       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.